Skip links

Author: oncologs.com

MSK Research Highlights, September 3, 2024

New research from Memorial Sloan Kettering Cancer Center (MSK) uses cryo-electron microscopy to shed new light on the ubiquitin; could help predict the risk of blood clots in cancer patients; reveals why micronuclei burst, accelerating aggressive cancers; and surveys healthcare providers about the benefits and

Hundreds of new cancer driver genes predicted by algorithm

Researchers at the Centre for Genomic Regulation (CRG) have discovered hundreds of potential new cancer driver genes. The findings, published in the journal Nature Communications, significantly expands the list of possible therapeutic targets to monitor and tackle the disease. Credit: Miquel Anglada Girotto/Centro de Regulación

Targeted cancer therapies: Getting radioactive atoms to accumulate in tumors

Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are diagnosed annually. While reducing testosterone and other male hormones can be an effective treatment for prostate cancer, this approach becomes ineffective
Explore
Drag